We and others identified that c-Met is mostly activated by ligand-independent mechanisms in HCC including chromosomal or mutational re-arrangements, receptor crosstalk, noncoding RNAs, and heparan sulfate proteoglycans11,35. This evidence concerns the gene MET and hepatocellular carcinoma.